149 related articles for article (PubMed ID: 33021149)
1. Computational studies of the properties and activities of selected trisubstituted benzimidazoles as potential antitubercular drugs inhibiting MTB-FtsZ polymerization.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
J Biomol Struct Dyn; 2022 Mar; 40(4):1558-1570. PubMed ID: 33021149
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
[TBL] [Abstract][Full Text] [Related]
3. Identifying the analogues of berberine as promising antitubercular drugs targeting Mtb-FtsZ polymerisation through ligand-based virtual screening and molecular dynamics simulations.
Akinpelu OI; Kumalo HM; Mhlongo SI; Mhlongo NN
J Mol Recognit; 2022 Feb; 35(2):e2940. PubMed ID: 34910337
[TBL] [Abstract][Full Text] [Related]
4. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
[TBL] [Abstract][Full Text] [Related]
6. SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.
Awasthi D; Kumar K; Knudson SE; Slayden RA; Ojima I
J Med Chem; 2013 Dec; 56(23):9756-70. PubMed ID: 24266862
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.
Park B; Awasthi D; Chowdhury SR; Melief EH; Kumar K; Knudson SE; Slayden RA; Ojima I
Bioorg Med Chem; 2014 May; 22(9):2602-12. PubMed ID: 24726304
[TBL] [Abstract][Full Text] [Related]
8. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
[TBL] [Abstract][Full Text] [Related]
9. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
Qiu Y; Zhou L; Hu Y; Bao Y
J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
[TBL] [Abstract][Full Text] [Related]
10. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting
Haranahalli K; Tong S; Kim S; Awwa M; Chen L; Knudson SE; Slayden RA; Singleton E; Russo R; Connell N; Ojima I
RSC Med Chem; 2021 Jan; 12(1):78-94. PubMed ID: 34046600
[TBL] [Abstract][Full Text] [Related]
12. Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies.
Rajasekhar S; Karuppasamy R; Chanda K
J Comput Chem; 2021 Sep; 42(24):1736-1749. PubMed ID: 34216033
[TBL] [Abstract][Full Text] [Related]
13. Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations Approach.
Tripathy S; Sahu SK; Azam MA; Jupudi S; Gupta VK; Sharma S
Curr Comput Aided Drug Des; 2021; 17(6):806-816. PubMed ID: 32748754
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents.
Yalcin-Ozkat G; Ersan RH; Ulger M; Ulger ST; Burmaoglu S; Yildiz I; Algul O
J Biomol Struct Dyn; 2023 Apr; 41(7):2667-2686. PubMed ID: 35132948
[TBL] [Abstract][Full Text] [Related]
15. An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors.
Khadkikar P; Goud NS; Mohammed A; Ramamoorthy G; Ananthathatmula R; Doble M; Rizvi A; Banerjee S; Ravi A; Alvala M
Chem Biol Drug Des; 2018 Dec; 92(6):1933-1939. PubMed ID: 30003661
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study.
Mitra K; Chadha A; Doble M
Eur J Pharm Sci; 2019 Jul; 135():103-112. PubMed ID: 31034983
[TBL] [Abstract][Full Text] [Related]
17. Bacterial FtsZ inhibition by benzo[
Dhameliya TM; Tiwari R; Patel KI; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Future Med Chem; 2022 Oct; 14(19):1361-1373. PubMed ID: 36103222
[No Abstract] [Full Text] [Related]
18. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
19. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening and biological evaluation of novel inhibitors of mycobacterium Z-ring formation.
Alexey R; Dariya S; Liudmyla I; Lilia V; Valeriy M; Dmytro L; Oleksandr B; Svitlana S; Sergii O; Elijah B; Mariia S; Yaroslav B; Pavel K
J Cell Biochem; 2022 May; 123(5):852-862. PubMed ID: 35297088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
